Publikationen, an denen er mitarbeitet Francisco José López Hernández (21)

2024

  1. A wide scope, pan-comparative, systematic meta-analysis of the efficacy of prophylactic strategies for cardiac surgery-associated acute kidney injury

    Biomedicine and Pharmacotherapy, Vol. 178

  2. Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis

    Frontiers in Pharmacology, Vol. 15

  3. Urinary GM2AP coincides with renal cortical damage and grades cisplatin nephrotoxicity severity in rats

    Toxicology, Vol. 508

2023

  1. Identification of Pre-Renal and Intrinsic Acute Kidney Injury by Anamnestic and Biochemical Criteria: Distinct Association with Urinary Injury Biomarkers

    International journal of molecular sciences, Vol. 24, Núm. 3

2022

  1. Diagnosis of Cardiac Surgery-Associated Acute Kidney Injury: State of the Art and Perspectives

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Neural Network-Based Calculator for Rat Glomerular Filtration Rate

    Biomedicines, Vol. 10, Núm. 3

  3. Protective Effect of Quercetin 3-O-Glucuronide against Cisplatin Cytotoxicity in Renal Tubular Cells

    Molecules, Vol. 27, Núm. 4

2021

  1. A micellar formulation of quercetin prevents cisplatin nephrotoxicity

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-14

  2. Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 21

  3. Are antioxidants useful in preventing the progression of chronic kidney disease?

    Antioxidants, Vol. 10, Núm. 11

  4. Regression modeling of the antioxidant-to-nephroprotective relation shows the pivotal role of oxidative stress in cisplatin nephrotoxicity

    Antioxidants, Vol. 10, Núm. 9

  5. The furosemide stress test and computational modeling identify renal damage sites associated with predisposition to acute kidney injury in rats

    Translational Research, Vol. 231, pp. 76-91

  6. Urinary Plasminogen Activator Inhibitor-1: A Biomarker of Acute Tubular Injury

    American Journal of Nephrology, Vol. 52, Núm. 9, pp. 714-724

2020

  1. A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application

    Critical Reviews in Toxicology, Vol. 50, Núm. 9, pp. 780-800

  2. Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury

    Scientific Reports, Vol. 10, Núm. 1

  3. Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity

    European Journal of Clinical Pharmacology, Vol. 76, Núm. 1, pp. 23-33

  4. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations

    Biomedicine and Pharmacotherapy, Vol. 121

2019

  1. Quercetin, a promising clinical candidate for the prevention of contrast-induced nephropathy

    International Journal of Molecular Sciences, Vol. 20, Núm. 19

2017

  1. A systematic meta-analysis on the efficacy of pre-clinically tested nephroprotectants at preventing aminoglycoside nephrotoxicity

    Toxicology, Vol. 377, pp. 14-24

  2. Key role of oxidative stress in animal models of aminoglycoside nephrotoxicity revealed by a systematic analysis of the antioxidant-to-nephroprotective correlation

    Toxicology, Vol. 385, pp. 10-17